反応式
[N:1]1([C:8]2[CH:13]=[CH:12][C:11]([N:14]3[CH2:23][CH2:22][C:21]4[C:16](=[CH:17][CH:18]=[C:19]([OH:24])[CH:20]=4)[C:15]3=[O:25])=[CH:10][C:9]=2[O:26][CH3:27])[CH2:7][CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.[CH3:28][C:29]1([O:32][CH2:31]1)[CH3:30]>CN1C(=O)CCC1>[OH:24][C:19]1[CH:20]=[C:21]2[C:16](=[CH:17][CH:18]=1)[C:15](=[O:25])[N:14]([C:11]1[CH:12]=[CH:13][C:8]([N:1]3[CH2:7][CH2:6][CH2:5][N:4]([CH2:28][C:29]([OH:32])([CH3:31])[CH3:30])[CH2:3][CH2:2]3)=[C:9]([O:26][CH3:27])[CH:10]=1)[CH2:23][CH2:22]2参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
A solution of 2-(4-[1,4]diazepan-1-yl-3-methoxy-phenyl)-6-hydroxy-3,4-dihydro-2H-isoquinolin-1-one (193 mg) and isobutylene oxide (300 mg) in NMP (0.8 mL) was stirred at 65° C. for 16 h. The reaction mixture was purified by preparative HPLC. In this way the product was obtained with molecular weight 439.56 (C25H33N3O4); MS (ESI): 440 (M+H+).
後処理
- customThe reaction mixture was purified by preparative HPLC
- customIn this way the product was obtained with molecular weight 439.56 (C25H33N3O4)
出典と根拠
- ORDレコード
- ord-c09888702117487ab49f1dadeb2f31fa
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08822495B2
関連ノート
読み込み中…